Financial reports and presentations

New Vaccibody publication

The newly published paper by Gunnveig Grodeland et al: DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza, describes the vaccibody platform as a robust and effective vaccine for prophylactic use. The paper can be downloaded here


Warning: Undefined array key "HTTP_REFERER" in /var/www/0/351003/www/wp-content/themes/nykode-understrap-child/loop-templates/content-single-financial.php on line 67

Go back